Compare · CUPR vs NVO
CUPR vs NVO
Side-by-side comparison of Cuprina Holdings (Cayman) Limited (CUPR) and Novo Nordisk A/S (NVO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. CUPR focuses on Industrial Specialties, while NVO focuses on Biotechnology: Pharmaceutical Preparations.
- NVO is the larger of the two at $184.33B, about 14254.0x CUPR ($12.9M).
- NVO has been more active in the news (7 items in the past 4 weeks vs 1 for CUPR).
- NVO has more recent analyst coverage (25 ratings vs 0 for CUPR).
- Company
- Cuprina Holdings (Cayman) Limited
- Novo Nordisk A/S
- Price
- -
- -
- Market cap
- $12.9M
- $184.33B
- 1M return
- -
- +6.11%
- 1Y return
- -
- -13.73%
- Industry
- Industrial Specialties
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 0
- 25
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Latest CUPR
- Amendment: SEC Form SCHEDULE 13G/A filed by Cuprina Holdings (Cayman) Limited
- SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited
- SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited
- Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
- SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited
- Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering
- SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited
- SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited
- Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
- SEC Form 424B4 filed by Cuprina Holdings (Cayman) Limited
Latest NVO
- Novo and DJ Khaled team up to take fans behind the scenes of the iconic musician's real-life "Walk, Golf, and Wegovy®" diet and weight-loss routine
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- Billions in New Plants, Trillions in Potential Obesity-Drug Revenue Over Two Decades
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S
- SEC Form 6-K filed by Novo Nordisk A/S